Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B, Nemazee D.

Science. 2006 Dec 22;314(5807):1936-8.

2.

Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.

Leenaars PP, Hendriksen CF, Angulo AF, Koedam MA, Claassen E.

Vet Immunol Immunopathol. 1994 Mar;40(3):225-41.

PMID:
8160361
3.

Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide.

McInerney TL, Brennan FR, Jones TD, Dimmock NJ.

Vaccine. 1999 Mar 17;17(11-12):1359-68.

PMID:
10195771
4.
5.

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC.

Science. 2007 Jun 15;316(5831):1628-32.

6.

Tolls and beyond--many roads to vaccine immunity.

Pulendran B.

N Engl J Med. 2007 Apr 26;356(17):1776-8. No abstract available.

PMID:
17460233
7.

Immunology: Toll-like receptors and antibody responses.

Nemazee D, Gavin A, Hoebe K, Beutler B.

Nature. 2006 May 18;441(7091):E4; discussion E4.

8.

Immunostimulatory activity of haptenated proteins.

Palm NW, Medzhitov R.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4782-7. doi: 10.1073/pnas.0809403105. Epub 2009 Mar 2.

9.

Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.

Moreira LO, Smith AM, DeFreitas AA, Qualls JE, El Kasmi KC, Murray PJ.

Vaccine. 2008 Oct 29;26(46):5808-13. doi: 10.1016/j.vaccine.2008.08.038. Epub 2008 Sep 27.

10.

Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.

Chilton PM, Hadel DM, To TT, Mitchell TC, Darveau RP.

Infect Immun. 2013 Sep;81(9):3317-25. doi: 10.1128/IAI.01150-12. Epub 2013 Jun 24.

11.

A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses.

Xiao L, Kim J, Lim M, Dai B, Yang L, Reed SG, Baltimore D, Wang P.

Vaccine. 2012 Mar 28;30(15):2570-81. doi: 10.1016/j.vaccine.2012.01.074. Epub 2012 Feb 5.

12.

Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.

Seubert A, Calabro S, Santini L, Galli B, Genovese A, Valentini S, Aprea S, Colaprico A, D'Oro U, Giuliani MM, Pallaoro M, Pizza M, O'Hagan DT, Wack A, Rappuoli R, De Gregorio E.

Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11169-74. doi: 10.1073/pnas.1107941108. Epub 2011 Jun 20.

13.
14.

Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.

Oscherwitz J, Hankenson FC, Yu F, Cease KB.

Vaccine. 2006 Apr 5;24(15):3018-25. Epub 2005 Nov 8.

PMID:
16307832
15.

Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.

Takeshita F, Tanaka T, Matsuda T, Tozuka M, Kobiyama K, Saha S, Matsui K, Ishii KJ, Coban C, Akira S, Ishii N, Suzuki K, Klinman DM, Okuda K, Sasaki S.

J Virol. 2006 Jul;80(13):6218-24.

16.
17.

B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation.

Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacoby D, Strom TB, Simpson EM, Freeman GJ, Sharpe AH.

Immunity. 1997 Mar;6(3):303-13.

18.

Control of B-cell responses by Toll-like receptors.

Pasare C, Medzhitov R.

Nature. 2005 Nov 17;438(7066):364-8.

PMID:
16292312
19.

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.

Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ.

Vaccine. 2007 Jan 8;25(4):763-75. Epub 2006 Aug 22.

PMID:
16968658
20.

Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

Skrastina D, Petrovskis I, Lieknina I, Bogans J, Renhofa R, Ose V, Dishlers A, Dekhtyar Y, Pumpens P.

PLoS One. 2014 Dec 1;9(12):e114006. doi: 10.1371/journal.pone.0114006. eCollection 2014.

Supplemental Content

Support Center